These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 14722939)

  • 1. [Treatment of drug resistant tuberculosis].
    Perel'man MI; Sokolova GB; Borisov SE; Kunichan AD; Lazareva IaV; Mozhokina GN; Elistratova NA; Tsybanev AA
    Antibiot Khimioter; 2003; 48(8):28-36. PubMed ID: 14722939
    [No Abstract]   [Full Text] [Related]  

  • 2. Further acquisition of drug-resistance in multidrug-resistant tuberculosis during chemotherapy.
    Toyota E; Sekiguchi J; Shimizu H; Fujino T; Otsuka Y; Yoshikura H; Kuratsuji T; Kirikae T; Kudo K
    Jpn J Infect Dis; 2004 Dec; 57(6):292-4. PubMed ID: 15623961
    [No Abstract]   [Full Text] [Related]  

  • 3. Tuberculosis drug resistance: summary report for 2003.
    Can Commun Dis Rep; 2004 May; 30(10):93-5. PubMed ID: 15174496
    [No Abstract]   [Full Text] [Related]  

  • 4. Drug resistance among tuberculosis patients attending diagnostic and treatment centres in Makassar, Indonesia.
    Massi MN; Wahyuni S; Halik H; ; Yusuf I; Leong FJ; Dick T; Phyu S
    Int J Tuberc Lung Dis; 2011 Apr; 15(4):489-95. PubMed ID: 21396208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medicine. New TB drug promises shorter, simpler treatment.
    Cohen J
    Science; 2004 Dec; 306(5703):1872. PubMed ID: 15591168
    [No Abstract]   [Full Text] [Related]  

  • 6. Wild-type distributions of seven oral second-line drugs against Mycobacterium tuberculosis.
    Schön T; Juréen P; Chryssanthou E; Giske CG; Sturegård E; Kahlmeter G; Hoffner S; Angeby KA
    Int J Tuberc Lung Dis; 2011 Apr; 15(4):502-9. PubMed ID: 21396210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Sensitivity of Mycobacterium tuberculosis in our environment].
    Unzaga MJ; Sota M; Melero P; Berdonces P; Ezpeleta C; Cisterna R
    Enferm Infecc Microbiol Clin; 1996; 14(6):399-400. PubMed ID: 8756225
    [No Abstract]   [Full Text] [Related]  

  • 8. The Mycobacterium tuberculosis Beijing genotype does not affect tuberculosis treatment failure in Vietnam.
    Buu TN; Huyen MN; van Soolingen D; Lan NT; Quy HT; Tiemersma EW; Borgdorff MW; Cobelens FG
    Clin Infect Dis; 2010 Oct; 51(8):879-86. PubMed ID: 20836697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Incidence of resistant mutants of Mycobacterium tuberculosis (MT) strains from different areas of Rumania. Bacteriological study--epidemiological aspects].
    Anastasatu C; Băicoianu S; Teodorescu A
    Arch Roum Pathol Exp Microbiol; 1970; 29(1):212-22. PubMed ID: 4998673
    [No Abstract]   [Full Text] [Related]  

  • 10. [Drug-resistance in Mycobacterium tuberculosis in Castilla y León, Spain, 2001-2005: third collaborative study].
    Alberte-Castiñeiras A; Campos-Bueno A; López-Urrutia L; Alvarez-Alonso E; Megías G; Ojeda-Fernández E; López-Medrano R; Iglesias-García J; García-Carbajosa S; Pérez-Pascual P
    Enferm Infecc Microbiol Clin; 2010 Dec; 28(10):706-9. PubMed ID: 20627375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resistance to anti-tuberculosis medications in the Horn of Africa.
    Ollé-Goig JE; Codina-Grau G; Martín-Casabona N
    Int J Tuberc Lung Dis; 2011 Mar; 15(3):414-6. PubMed ID: 21333114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microbiology. TB--a new target, a new drug.
    Cole ST; Alzari PM
    Science; 2005 Jan; 307(5707):214-5. PubMed ID: 15653490
    [No Abstract]   [Full Text] [Related]  

  • 13. [Progress in the study of drug susceptibility testing of Mycobacterium tuberculosis].
    Zhang YY; Wan KL
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Dec; 25(12):1074-7. PubMed ID: 15769370
    [No Abstract]   [Full Text] [Related]  

  • 14. Detection of and treatment protocol for rifampicin-monoresistant tuberculosis: what is the role of isoniazid?
    Velayati AA; Farnia P; Masjedi MR; Hoffner S
    Int J Tuberc Lung Dis; 2013 Jun; 17(6):849-50. PubMed ID: 23676176
    [No Abstract]   [Full Text] [Related]  

  • 15. Shortening the treatment of tuberculosis.
    Mitchison DA
    Nat Biotechnol; 2005 Feb; 23(2):187-8. PubMed ID: 15696148
    [No Abstract]   [Full Text] [Related]  

  • 16. Minimising moxifloxacin resistance with tuberculosis.
    Drlica K; Zhao X; Kreiswirth B
    Lancet Infect Dis; 2008 May; 8(5):273-5. PubMed ID: 18471768
    [No Abstract]   [Full Text] [Related]  

  • 17. Compounds for use in the treatment of mycobacterial infections: a patent evaluation (WO2014049107A1).
    Pechalrieu D; Lopez M
    Expert Opin Ther Pat; 2015 Jun; 25(6):729-35. PubMed ID: 25752488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The within-host population dynamics of Mycobacterium tuberculosis vary with treatment efficacy.
    Trauner A; Liu Q; Via LE; Liu X; Ruan X; Liang L; Shi H; Chen Y; Wang Z; Liang R; Zhang W; Wei W; Gao J; Sun G; Brites D; England K; Zhang G; Gagneux S; Barry CE; Gao Q
    Genome Biol; 2017 Apr; 18(1):71. PubMed ID: 28424085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic polymorphism in Mycobacterium tuberculosis isolates from patients with chronic multidrug-resistant tuberculosis.
    Post FA; Willcox PA; Mathema B; Steyn LM; Shean K; Ramaswamy SV; Graviss EA; Shashkina E; Kreiswirth BN; Kaplan G
    J Infect Dis; 2004 Jul; 190(1):99-106. PubMed ID: 15195248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [An investigation on multiple drug resistance of the rifampin resistant strains of Mycobacterium tuberculosis].
    Kuang T; Jin G; Song P; Li W; Wang Z
    Wei Sheng Wu Xue Bao; 1998 Apr; 38(2):152-4. PubMed ID: 12549378
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.